Evidence map›Paper›PMID 38577454›Full record

ReviewWorld journal of gastrointestinal oncology2024

Prognostic and predictive role of immune microenvironment in colorectal cancer.

Olesya Kuznetsova, Mikhail Fedyanin, Larisa Zavalishina, Larisa Moskvina, Olga Kuznetsova, Alexandra Lebedeva, Alexey Tryakin, Galina Kireeva, Gleb Borshchev, Sergei Tjulandin and 1 more

Open access · diamondAbstract readReview

PubMed Full text at PMC Publisher

In one paragraph

Review in World journal of gastrointestinal oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it

0cells of the map it votes in

7citing papers in PubMed

1.7field-weighted citation impact, top 14% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

Watch and Wait Strategy for Locally Advanced Rectal Cancer: Update From Results of Recent Clinical Trials.Cancer medicine · 2026
Review
Immunoscore based on CD3American journal of cancer research · 2026
Article
A laminin α4-CD8Oncoimmunology · 2025
Article
Immunoscore: redefining the landscape of colorectal cancer control and care.Future oncology (London, England) · 2025
Review
Research progress on immunotherapy combined with neoadjuvant concurrent chemoradiotherapy in pMMR/MSS locally advanced rectal cancer.Frontiers in immunology · 2025
Review
Differences in the peripheral blood immune landscape between early-onset and late-onset colorectal cancer.Frontiers in immunology · 2025
Article
Systemic inflammatory response in colorectal cancer is associated with tumour mismatch repair and impaired survival.Scientific reports · 2024
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Olesya KuznetsovaDepartment of Chemotherapy, Federal State Budgetary Institution (N.N. Blokhin National Medical Research Center of Oncology) of the Ministry of Health of the Russian Federation, Moscow 115478, Russia. kuznetsova.o.md@gmail.com.

Mikhail FedyaninDepartment of Chemotherapy, Federal State Budgetary Institution (N.N. Blokhin National Medical Research Center of Oncology) of the Ministry of Health of the Russian Federation, Moscow 115478, Russia.

Larisa ZavalishinaDepartment of Pathology, Russian Medical Academy of Continuous Professional Education, Moscow 123242, Russia.

Larisa MoskvinaDepartment of Pathology, Russian Medical Academy of Continuous Professional Education, Moscow 123242, Russia.

Olga KuznetsovaDepartment of Pathology, Russian Medical Academy of Continuous Professional Education, Moscow 123242, Russia.

Alexandra LebedevaOncoAtlas LCC, Moscow 115478, Russia.

Alexey TryakinDepartment of Chemotherapy, Federal State Budgetary Institution (N.N. Blokhin National Medical Research Center of Oncology) of the Ministry of Health of the Russian Federation, Moscow 115478, Russia.

Galina KireevaFederal State Budgetary Institution "National Medical and Surgical Center named after N.I. Pirogov" of the Ministry of Health of the Russian Federation, Moscow 105203, Russia.

Gleb BorshchevFederal State Budgetary Institution "National Medical and Surgical Center named after N.I. Pirogov" of the Ministry of Health of the Russian Federation, Moscow 105203, Russia.

Sergei TjulandinDepartment of Chemotherapy, Federal State Budgetary Institution (N.N. Blokhin National Medical Research Center of Oncology) of the Ministry of Health of the Russian Federation, Moscow 115478, Russia.

Ekaterina IgnatovaSTOONCO: Science and Technology in Oncology, Moscow 115478, Russia.

National Medical Research Center of Cardiology · RUMinistry of Health · TONational Medical and Surgical Center named after N.I. Pirogov · RURussian Medical Academy of Continuous Professional Education · RUInstitute of Physics and Technology · RUMoscow City Oncology Hospital №62 · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) represents a molecularly heterogeneous disease and one of the most frequent causes of cancer-related death worldwide. The traditional classification of CRC is based on pathomorphological and molecular characteristics of tumor cells (mucinous, ring-cell carcinomas,

Indexed as

Colorectal cancerDigital pathologyGastrointestinal cancersImmune microenvironmentImmunoscorePredictive biomarkers

Identifiers

PMID38577454

DOI10.4251/wjgo.v16.i3.643

PMCPMC10989368

OpenAlexW4392727808

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.